Literature DB >> 20049468

Ovarian tumors associated with pregnancy: a 20-year experience in a teaching hospital.

Turki Gasim1, Sana A Al Dakhiel, Ahlam A Al Ghamdi, Mariam Al Ali, Fathia Al Jama, Jessica Rahman, Suleiman A Al Suleiman, Mohammad S Rahman.   

Abstract

OBJECTIVE: Pregnancy associated with ovarian tumors was reviewed over a 20-year period to determine the maternal and fetal outcome in patients undergoing surgery during pregnancy.
METHOD: A retrospective study of 94 cases of ovarian tumors treated surgically during pregnancy was investigated for incidence, clinico-pathological features and outcome in a teaching hospital between June 1987 and May 2007.
RESULTS: The overall incidence of ovarian tumor in pregnant women was 1 in 505 (0.2%) deliveries. Diagnosis of 69.2% tumors resulted in the first and second trimesters of pregnancy. Twenty-two (23.4%) patients presented as an emergency at different periods of gestation and 16 (17.1%) tumors were incidentally discovered at cesarean section which underlines the significance of examining the ovaries routinely at cesarean section. Benign teratoma (39.4%) and serous cystadenoma (24.5%) were the most common types of ovarian tumors found in the study. The incidence of malignant tumors was 5.3%. Tumors with low malignant potential comprised 40% of malignancy. The miscarriage rate after surgery was 44.4% in the first trimester compared with 16.6% in the second trimester. The preterm birth rate was 4.3% in the series.
CONCLUSION: The value of clinical and ultrasound examinations in early pregnancy as a diagnostic aid is highlighted. Whenever an ovarian tumor is detected in pregnancy, malignancy should always be suspected. Treatment of an ovarian tumor in pregnancy should be tailored according to the age, parity, clinical presentation, gestational age and histopathology of the tumor. Removal of persisting or enlarging ovarian masses as soon as possible is important to obtain a final histologic diagnosis and rule out malignancy. Early diagnosis and appropriate treatment of malignant tumors offers the best prognosis for the patient.

Entities:  

Mesh:

Year:  2010        PMID: 20049468     DOI: 10.1007/s00404-009-1346-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

1.  Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.

Authors:  Gali Epstein Shochet; Shelly Tartakover-Matalon; Liat Drucker; Metsada Pasmanik-Chor; Meir Pomeranz; Ami Fishman; Michael Lishner
Journal:  Clin Exp Metastasis       Date:  2014-10-15       Impact factor: 5.150

2.  Borderline ovarian tumor in pregnancy: can surgery wait? A case series.

Authors:  Ailyn M Vidal Urbinati; Anna D Iacobone; Raffaela C Di Pace; Ida Pino; Maria R Pittelli; Maria E Guerrieri; Eleonora P Preti; Dorella Franchi
Journal:  Arch Gynecol Obstet       Date:  2021-05-05       Impact factor: 2.344

3.  Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis.

Authors:  Liya Wang; Shenjiao Huang; Xiujie Sheng; Chenchen Ren; Qiming Wang; Linqing Yang; Shuping Zhao; Tianmin Xu; Xiaoxin Ma; Ruixia Guo; Pengming Sun; Yang Lin; Yuhong Li; Jiandong Wang; Yudong Wang
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

4.  Fractalkine receptor is expressed in mature ovarian teratomas and required for epidermal lineage differentiation.

Authors:  Lisa Rooper; Hilal Gurler; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  J Ovarian Res       Date:  2013-08-17       Impact factor: 4.234

Review 5.  A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Authors:  Stergios Boussios; Michele Moschetta; Konstantina Tatsi; Alexandros K Tsiouris; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2018-03-06       Impact factor: 10.479

Review 6.  Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis.

Authors:  Yaping Pei; Yuanfeng Gou; Na Li; Xiaojuan Yang; Xue Han; Liu Huiling
Journal:  Oncol Ther       Date:  2021-12-04

7.  Large malignant ovarian tumors during pregnancy: two cases.

Authors:  Dong Xu; Cheng Liang; Jing He
Journal:  Onco Targets Ther       Date:  2014-11-17       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.